EVERY Company Secures $55 Million in Funding
The EVERY Company has secured $55 million in a Series D funding round, led by McWin Capital Partners, with participation from investors including Main Sequence, Bloom8, and Minerva Foods.
This funding will support the company's expansion into the US market as it scales up its production of precision-fermented egg proteins.
EVERY is proving that biomanufacturing has the potential to transform the food industry
Products and Technology
EVERY's fermentation-based technology offers alternatives to traditional egg proteins, including OvoPro™ and OvoBoost™, designed to replace conventional eggs in products such as baked goods, beverages, and protein supplements.
- OvoPro™: a substitute for egg whites
- OvoBoost™: a neutral protein for various food and beverage applications
Author's summary: EVERY Company secures funding to scale egg protein production.
More News
- What to Know About 2026 Concerts at Empower Field at Mile High
- REVEALED: What the report into ‘bully’ Neil Foden’s offending has found
- HH: Rumbling, stumbling TD topples Tennessee; Nebraska AD achieves dumbassery
- Heura Launches Plant-Based Frankfurter and Shares Recipe with Meat Industry Leaders - vegconomist - the vegan business magazine
- Jonathan Bailey is People's Sexiest Man Alive 2025... but is he the next Batman?!
- Red Kettle Ringer Alert: Bell County Needs Volunteers to Raise Crucial $125K
- Mating injuries lead scientists to identify female dinosaurs
- Jake Paul’s Body Language Analyzed After Gervonta Davis Fight Canceled
- Jonathan Bailey is People's Sexiest Man Alive 2025... but is he the next Batman?!
- Watch: Hugh Jackman, Kate Hudson form Neil Diamond tribute band in 'Song Sung Blue' - UPI.com